NCT05950984View on ClinicalTrials.gov

Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

October 30, 2023

Primary Completion Date

August 28, 2024

Study Completion Date

August 28, 2024

Conditions
Infection, BacterialAntibiotic Side EffectAntibiotic Resistant InfectionSepsisSeptic ShockBacteremiaCritical IllnessAdult Children
Interventions
OTHER

Drug Infusion Pump Monitoring

Intravenous vancomycin administration accuracy will be determined by comparing data obtained from drug infusion pumps with manually input administration times from the electronic Prescribing and Medicines Administration (ePMA) system.

Trial Locations (1)

SW17 0QT

St Georges University Hospitals NHS Foundation Trust, London

All Listed Sponsors
collaborator

University College, London

OTHER

lead

St George's, University of London

OTHER

NCT05950984 - Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK) | Biotech Hunter | Biotech Hunter